Celldex (CLDX)
35.42
+0.65 (1.87%)
Upcoming Events
Latest Headlines
Celldex Therapeutics (CLDX) PT Lowered to $40 at Morgan Stanley
July 22, 2026 8:25 AM - StreetInsider
Celldex Therapeutics (CLDX) PT Lowered to $61 at Cantor Fitzgerald
July 22, 2026 6:59 AM - StreetInsider
Celldex Therapeutics (CLDX) PT Lowered to $60 at Canaccord
July 22, 2026 6:39 AM - StreetInsider
Celldex Therapeutics (CLDX) PT Lowered to $48 at Wells Fargo
July 22, 2026 6:26 AM - StreetInsider
After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
July 21, 2026 4:37 PM - StreetInsider
Celldex's barzolvolimab fails Phase 2 trial in prurigo nodularis
July 21, 2026 4:01 PM - StreetInsider
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
July 21, 2026 4:01 PM - Globe NewsWire
Celldex Therapeutics (CLDX) PT Raised to $100 at Guggenheim
July 20, 2026 7:05 AM - StreetInsider
Form 8-K Celldex Therapeutics, For: Jul 10
July 15, 2026 4:08 PM - SEC Filing
Celldex CFO Sam Martin to retire in 2027 after nearly two decades
July 15, 2026 4:01 PM - StreetInsider
Celldex Announces Planned Transition of Chief Financial Officer
July 15, 2026 4:01 PM - Globe NewsWire
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Lawver Teri L
June 29, 2026 4:22 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Jimenez Freddy A.
June 29, 2026 4:21 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Young Diane C.
June 29, 2026 4:20 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Heath-Chiozzi Margo
June 29, 2026 4:20 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Martin Samuel Bates
June 29, 2026 4:19 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Cavanaugh Sarah
June 29, 2026 4:18 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Crowley Elizabeth
June 29, 2026 4:17 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: PEPIN RONALD
June 29, 2026 4:16 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: KELER TIBOR
June 29, 2026 4:15 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Marucci Anthony S
June 29, 2026 4:14 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Torres Denice
June 29, 2026 4:13 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Jain Rita
June 29, 2026 4:12 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: NEIL GARRY ARTHUR
June 29, 2026 4:11 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Cohen Cheryl
June 29, 2026 4:10 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: Brownlie Keith L
June 29, 2026 4:09 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: MARINO JAMES J
June 29, 2026 4:09 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: CONRAD HERBERT J
June 29, 2026 4:07 PM - SEC Filing
Form 4 Celldex Therapeutics, For: Jun 25 Filed by: PENNER HARRY JR
June 29, 2026 4:07 PM - SEC Filing
Form S-8 Celldex Therapeutics,
June 26, 2026 4:02 PM - SEC Filing
Form 8-K Celldex Therapeutics, For: Jun 25
June 26, 2026 8:44 AM - SEC Filing
Guggenheim flags this biotech stocks as one of its top picks
June 18, 2026 11:00 PM - StreetInsider
UBS Reiterates Buy Rating on Celldex Therapeutics (CLDX)
June 16, 2026 9:28 AM - StreetInsider
Celldex reports sustained angioedema improvements 7 months post-treatment
June 14, 2026 2:00 PM - StreetInsider
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual
June 14, 2026 10:21 AM - Globe NewsWire
Celldex reports positive phase 1 results for bispecific antibody CDX-622
June 14, 2026 5:15 AM - StreetInsider
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
June 14, 2026 5:15 AM - Globe NewsWire
Celldex to present mast cell targeting drug data at European congress
June 10, 2026 4:01 PM - StreetInsider
Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
June 10, 2026 4:01 PM - Globe NewsWire
Celldex Therapeutics (CLDX) PT Raised to $45 at UBS
June 10, 2026 8:37 AM - StreetInsider
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP
May 15, 2026 4:02 PM - SEC Filing
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Bellevue Group AG
May 15, 2026 2:37 PM - SEC Filing
Celldex Therapeutics (CLDX) PT Raised to $54 at Wells Fargo
May 13, 2026 6:04 AM - StreetInsider
Form SCHEDULE 13G Celldex Therapeutics, Filed by: STATE STREET CORP
May 12, 2026 10:19 AM - SEC Filing
Celldex Therapeutics (CLDX) PT Raised to $48 at Barclays
May 8, 2026 4:05 AM - StreetInsider
Celldex (CLDX) Tops Q1 EPS by 1c
May 7, 2026 5:45 PM - StreetInsider
Form 10-Q Celldex Therapeutics, For: Mar 31
May 7, 2026 4:09 PM - SEC Filing
Form 8-K Celldex Therapeutics, For: May 07
May 7, 2026 4:02 PM - SEC Filing
Celldex Reports First Quarter Financial Results and Provides Corporate Update
May 7, 2026 4:01 PM - Globe NewsWire
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: FMR LLC
May 6, 2026 11:07 AM - SEC Filing
Form SCHEDULE 13G Celldex Therapeutics, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 5:36 PM - SEC Filing
Form ARS Celldex Therapeutics, For: Dec 31
April 29, 2026 8:02 AM - SEC Filing
Form DEF 14A Celldex Therapeutics, For: Jun 25
April 29, 2026 8:01 AM - SEC Filing
Full Article List
